PMC4076446_01
MRI pituitary before (A) and 6 months after (B) cabergoline treatment.
ccrep-7-2014-049f1.jpg
PMC4076446_01_ccrep-7-2014-049f1.jpg
f1-ccrep-7-2014-049
Table 1 shows the effect of cabergoline at a dose of 0.25 mg twice weekly over 5 months (September 2013), with the latest results including MRI images before and after treatment (Fig. 1) as well as after 13 months (Fig. 2).